Finance

Beta
Lists
CRBU:NASDAQ
Caribou Biosciences Inc
$1.68
+7.01%
(+0.11) 1D
$1.65
-1.71% (-0.029)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBU...
Open
$1.57
High
$1.73
Low
$1.56
Mkt. cap
166.62M
Avg. vol.
1.93M
Volume
13.89M
52-wk high
$3.54
52-wk low
$1.22
EPS
-$1.42
Beta
2.33
Shares outstanding
99.18M
No. of employees
97
Open
$1.57
High
$1.73
Low
$1.56
Mkt. cap
166.62M
Avg. vol.
1.93M
Volume
13.89M
52-wk high
$3.54
52-wk low
$1.22
EPS
-$1.42
Beta
2.33
Shares outstanding
99.18M
No. of employees
97
News stories
From sources across the web
About Caribou Biosciences Inc
CEO-
Employees97
FoundedJan 1, 2011
HeadquartersBerkeley, California, United States
SectorBiotechnology
Websitecariboubio.com
Analyst ratings
Based on 4 analysts giving stock ratings to CRBU in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRBU in the last 3 months.
Highest
Current $1.68
$11.00 (+554.76%)
Average
$8.75 (+420.83%)
Lowest
$6.00 (+257.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
$11.00
+554.8%
06/16/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$8.00
+376.2%
06/11/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
$6.00
+257.1%
06/11/2026
Luca Issi
RBC Capital
Buy
Maintained
$10.00
+495.2%
05/08/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$13.00
+673.8%
03/09/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
$7.00
+316.7%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$4.00
+138.1%
03/06/2026
William Maughan
Clear Street
Buy
Maintained
$13.00
+673.8%
03/06/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.26 / -$0.31
+16.13%beat
Revenue / Est. (USD)
2.40M / 2.18M
+9.88%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.67M
2.20M
3.94M
2.40M
Cost of goods sold
27.69M
22.40M
23.82M
20.61M
Cost of revenue
27.69M
22.40M
23.82M
20.61M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.40M
9.20M
8.58M
8.07M
Operating expense
10.40M
9.20M
8.58M
8.07M
Total operating expenses
38.10M
31.60M
32.39M
28.68M
Operating income
-35.43M
-29.40M
-28.45M
-26.28M
Other non operating income
451.00K
-
42.00K
-
EBT including unusual items
-54.10M
-27.55M
-27.04M
-25.08M
EBT excluding unusual items
-41.95M
-27.55M
-27.04M
-25.08M
Income tax expense
-
-
-550.00K
-
Effective tax rate
-
-
2.03%
-
Other operating expenses
-
-
-
-
Net income
-54.10M
-27.55M
-26.49M
-25.08M
Net profit margin
-2,028.42%
-1,253.32%
-672.11%
-1,046.52%
Earnings per share
-0.35
-
-
-0.26
Interest and investment income
2.19M
1.85M
1.37M
1.20M
Interest expense
-
-
-
-
Net interest expenses
2.19M
1.85M
1.37M
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-34.26M
-28.77M
-27.77M
-25.63M
Gain or loss from assets sale
-25.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CRBU
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer